On November 13, President Donald Trump nominated Alex Azar as the next secretary of the U.S. Department of Health and Human Services (HHS).
Azar, if confirmed, would succeed Tom Price, MD, who resigned in September after allegedly using private and government planes at taxpayer expense.
Price, a former surgeon, was seen as someone who could advocate for fellow physicians, whereas Azar’s background in healthcare is rooted in law. He is currently founder and chairman of Indianapolis-based Seraphim Strategies, a consulting firm providing insight into the biopharmaceutical and health insurance industries.
Until January, he was president of pharma giant Lilly USA, a subsidiary of Eli Lilly. He earned his bachelor’s degree in economics at Dartmouth College in Hanover, New Hampshire, before attending Yale Law School, where he earned his JD in 1991.
Here are some other things physicians should know about Azar as he awaits hearings in Senate.